Organogenesis Holdings (ORGO) Cash from Investing Activities Growth (1y) (2019 - 2026)
Organogenesis Holdings (ORGO) Cash from Investing Activities Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -308.05% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -41.51% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -139.86% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 129.18% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.71% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -366.90% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -96.43% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn | 69.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 69.76% |
| Mar 31, 2026 | 13.24% |
| Dec 31, 2025 | -38.41% |
| Sep 30, 2025 | 13.00% |
| Jun 30, 2025 | -93.51% |
| Mar 31, 2025 | -63.19% |
| Dec 31, 2024 | -1.11% |
| Sep 30, 2024 | 57.03% |
| Jun 30, 2024 | 74.93% |
| Mar 31, 2024 | 70.62% |
| Dec 31, 2023 | 68.81% |
| Sep 30, 2023 | 42.52% |
| Jun 30, 2023 | -21.58% |
| Mar 31, 2023 | -13.34% |
| Dec 31, 2022 | -103.86% |
| Sep 30, 2022 | 37.72% |
| Jun 30, 2022 | -42.35% |
| Mar 31, 2022 | -34.60% |
| Dec 31, 2021 | 3.53% |
| Sep 30, 2021 | -39.63% |